Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIF1C | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | MAGEA9 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | RNF112 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | NLRC3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | LRP10 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | GLYCTK | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | IL5 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | PCGF5 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | THTPA | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | PACSIN2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |